These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23383108)

  • 21. Characterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37.
    Cao C; Bai Y; Holloway MJ; Edgeworth RL; Jackson EA; Cotropia J; Ugen KE
    DNA Cell Biol; 2004 Dec; 23(12):836-41. PubMed ID: 15684710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.
    Wang S; York J; Shu W; Stoller MO; Nunberg JH; Lu M
    Biochemistry; 2002 Jun; 41(23):7283-92. PubMed ID: 12044159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection.
    Hovanessian AG; Briand JP; Said EA; Svab J; Ferris S; Dali H; Muller S; Desgranges C; Krust B
    Immunity; 2004 Nov; 21(5):617-27. PubMed ID: 15539149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41.
    Weng Y; Weiss CD
    J Virol; 1998 Dec; 72(12):9676-82. PubMed ID: 9811701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones.
    Speth C; Joebstl B; Barcova M; Dierich MP
    AIDS; 2000 Apr; 14(6):629-36. PubMed ID: 10807185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
    Cao J; Bergeron L; Helseth E; Thali M; Repke H; Sodroski J
    J Virol; 1993 May; 67(5):2747-55. PubMed ID: 8474172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer analysis of the amino acid sequences in gp41 of apathogenic African green monkey (AGM) virus, less pathogenic HIV-2 and highly pathogenic SIV and HIV-1 lentiviruses.
    Becker Y
    Virus Genes; 1992 Nov; 6(4):319-32. PubMed ID: 1335629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.
    Bugge TH; Lindhardt BO; Hansen LL; Kusk P; Hulgaard E; Holmbäck K; Klasse PJ; Zeuthen J; Ulrich K
    J Virol; 1990 Sep; 64(9):4123-9. PubMed ID: 1696634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.
    Robinson WE; Gorny MK; Xu JY; Mitchell WM; Zolla-Pazner S
    J Virol; 1991 Aug; 65(8):4169-76. PubMed ID: 2072448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region.
    Apellániz B; Rujas E; Serrano S; Morante K; Tsumoto K; Caaveiro JM; Jiménez MÁ; Nieva JL
    J Biol Chem; 2015 May; 290(21):12999-3015. PubMed ID: 25787074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.
    Jiang S; Lin K; Zhang L; Debnath AK
    J Virol Methods; 1999 Jun; 80(1):85-96. PubMed ID: 10403680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 Motif.
    Klug YA; Schwarzer R; Rotem E; Charni M; Nudelman A; Gramatica A; Zarmi B; Rotter V; Shai Y
    Biochemistry; 2019 Feb; 58(6):818-832. PubMed ID: 30602116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV gp41 pocket binding domain enables C-terminal heptad repeat transition from mediating membrane fusion to immune modulation.
    Klug YA; Kapach G; Rotem E; Dubreuil B; Shai Y
    Biochem J; 2016 Apr; 473(7):911-8. PubMed ID: 26823547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.
    He Y; Liu S; Jing W; Lu H; Cai D; Chin DJ; Debnath AK; Kirchhoff F; Jiang S
    J Biol Chem; 2007 Aug; 282(35):25631-9. PubMed ID: 17616522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enriching for HIV-infected cells using anti-gp41 antibodies indirectly conjugated to magnetic microbeads.
    Bahbouhi B; al-Harthi L
    Biotechniques; 2004 Jan; 36(1):139-47. PubMed ID: 14740496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
    Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
    J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.